CVB Amends Veterinary Biologics Regulations

May 13, 2015 — 

The USDA Center for Veterinary Biologics (CVB) is amending the Virus-Serum-Toxin Act regulations (9 CFR Part 107.1) to require that veterinary biologics prepared under the veterinary practitioner exemption must be prepared at the same facility the veterinarian utilizes in conducting the day-to-day activities associated with his or her practice. This exemption applies to veterinary biologics prepared by a veterinary practitioner solely for administration to animals in the course of a State-licensed professional practice of veterinary medicine under a veterinarian-client-patient relationship. This rule is necessary to ensure that veterinary biologics are not prepared in unlicensed establishments in violation of the Virus-Serum-Toxin Act and to clarify the regulations regarding the preparation of product by a veterinary practitioner under a veterinarian-client-patient relationship.

This final rule for the revision of 9 CFR 107.1 will be effective July 10, 2015. The Center for Veterinary Biologics (CVB) recently added a final rule for the revision of Title 9 Code of Federal Regulations Part 107, Section 1 (9 CFR 107.1) to its website which may be accessed by clicking the following link: CVB Newly Published Information.